U.S. Pharmacist

 
 

  • Overcoming Barriers to Statin Adherence Poor adherence can be a significant barrier to effective statin therapy. What steps can be taken to improve adherence and manage intolerance and other adverse effects?
  • Anticoagulation in Pediatrics: DOACs on the Horizon DOACs have not yet been approved for pediatric use. This article reviews current studies and what you should know regarding selecting appropriate anticoagulation therapy for children.
  • Updates in the Management of Clostridium difficile for Adults This article reviews recent guideline updates for the treatment of C. difficile infection, which reflect significant changes from previous recommendations.
  • OTC Transdermal Analgesic Patches in Pain Management Review the use of over-the-counter transdermal pain patches in this article. Which types are most effective, and how should you counsel patients on their proper use?
  • Management of Acute Ischemic Stroke: Guideline Updates This paper summarizes 2018 guidelines by the American Heart Association/American Stroke Association outlining optimal treatment for early management of patients with acute ischemic stroke.
  • Crohn's Disease Treatment Update This article presents the American College of Gastroenterology's updated guidelines on managing Crohn's disease in adult patients.
  • Alzheimer's Disease: Current and Potential New Treatments This paper reviews the pharmacological options which are currently available for treatment of Alzheimer disease, as well as potential new agents and approaches under investigation.
  • Management of Nightmare Disorder in Adults Review the options for nonpharmacologic and pharmacologic treatment of adult nightmare disorder as presented in a 2018 position paper by the American Academy of Sleep Medicine.
  • Applying Recent A1C Recommendations in Clinical Practice Three clinical guidelines were published in 2018 that address the use of A1C in the diagnosis and management of diabetes mellitus--but they don't all agree. Explore the controversy in this paper.
  • Role of PARP Inhibitors in BRCA-Related Malignancies Review the pharmacology of PARP inhibitors and their use in BRCA-mutated malignancies including breast, ovarian, fallopian tube, and primary peritoneal cancers.
  • Prostate Cancer Review This review summarizes current approaches to prostate cancer screening, diagnosis, and treatment. What recent advances have been made in characterizing disease risk and expanding therapeutic options?
  • Managing Chronic and Acute COPD Exacerbations Review an updated pharmacotherapy treatment algorithm and new recommendations for the prevention and management of acute COPD exacerbations as presented in the latest GOLD guidelines.
  • Updates in Pharmacotherapy for Melanoma This article reviews the latest new and emerging systemic therapies for advanced melanoma, including immunotherapy and targeted therapy.
  • Hormonal Contraceptive Consent by Minors Under what circumstances and in which states can minors obtain hormonal contraceptives without parental consent? Review the legal and confidentiality requirements of this situation in this article.
  • Managing Neurologic Complications of Chronic HCV Infection This article highlights some of the extrahepatic and neurologic complications of chronic HCV infection. What role can the community pharmacist play in their identification and management?
  • Heart Failure Guidelines: Introduction to the New Agents Review updated guidelines for the management of heart failure that have been revised to include the two novel pharmacologic agents sacubitril/valsartan and ivabradine.
  • Pharmacotherapy for Primary Headache Disorders in the ED This article reviews assessment and treatment of patients who present in the emergency department with headache. What options are available for treating acute headache in this setting?
  • Irritable Bowel Syndrome: A Review of Treatment Options This article summarizes the latest in nonpharmacologic treatment options and drug therapy for irritable bowel syndrome. What should be the initial approach to management?
  • Metabolic Challenges in Mental Health This review examines potential adverse metabolic side effects associated with antipsychotic drugs, which can lead to an increased risk of metabolic syndrome in patients with serious mental illness.
  • Sodium-Glucose Cotransporter 2 Inhibitors: An Overview SGLT2 inhibitors are promising new agents for the treatment of type 2 diabetes, but there are risks to be considered. Which patients would most benefit?